How branched-chain amino acids affect health and aging

The regulation of health and longevity by branched-chain amino acids

NIH-funded research University of Wisconsin-Madison · NIH-10539009

This study is looking at how certain proteins called branched-chain amino acids (BCAAs) might affect health and aging, especially for older adults, to see if changing their diet could help prevent diseases like Alzheimer's and improve overall well-being.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison NIH-funded
Lab location1 site (Madison, United States)
Project IDNIH-10539009 on NIH RePORTER

What this research studies

This research investigates the role of branched-chain amino acids (BCAAs) in regulating health and longevity, particularly in older adults. It explores how dietary protein, specifically the restriction of BCAAs like leucine, isoleucine, and valine, can influence age-related diseases such as Alzheimer's and frailty. The study employs a combination of dietary interventions and metabolic assessments to understand the effects of BCAA consumption on health outcomes in aging populations. By examining these relationships, the research aims to identify potential dietary strategies that could improve the quality of life for seniors.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults, particularly those at risk for age-related diseases like Alzheimer's or frailty.

Not a fit: Patients who are not elderly or do not have age-related health concerns may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to dietary recommendations that enhance health and longevity in older adults.

How similar studies have performed: Previous studies have shown promising results regarding dietary protein restriction and its effects on longevity, suggesting this approach may be effective.

Where this research is happening

Madison, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.